ஆண்டு ஐரோப்பிய சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆண்டு ஐரோப்பிய சங்கம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆண்டு ஐரோப்பிய சங்கம் Today - Breaking & Trending Today

Nucleix Presents Clinical Data at EAU21 Virtual Congress Which Demonstrates Promising Advances in the Care of Bladder Cancer Patients


Share:
Data Includes First Real World Evidence on Alternating Bladder EpiCheck® and Cystoscopy for Surveillance of Non-Muscle Invasive Bladder Cancer (NMIBC)
Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced data from two abstracts featuring its Bladder EpiCheck® test at the 36th Annual European Association of Urology (EAU) Virtual Congress.
The first abstract titled, Real world evidence of alternating cystoscopy/cytology with Bladder EpiCheck in NMIBC surveillance, shows the results of a pilot performed at Radboud University Medical Center evaluating the feasibility and clinical outcomes of alternating between cystoscopy/cytology and Bladder EpiCheck in non-muscle invasive bladder cancer (NMIBC) surveillance. To alleviate the burden of invasive and costly standard surveillance methods on patients, urine collection was performed at home and shipped to a central lab to perform the Bladder EpiCheck tes ....

United States , Comunidad Autonoma De Cataluna , Fred Witjes , Alberto Breda , Radboud University Medical Center , European Association Of Urology , Radboud University , Virtual Congress , Data Includes First Real World Evidence , Alternating Bladder Epicheck , Non Muscle Invasive Bladder Cancer , Bladder Epicheck , Annual European Association , Medical Sciences , Radboud University Medical , Lung Epicheck , Urology Oncology , ஒன்றுபட்டது மாநிலங்களில் , காமுனிடட தன்னாட்சி டி கடலுள் , ஆல்பர்டோ ப்ரேடா , ஐரோப்பிய சங்கம் ஆஃப் சிறுநீரகம் , மெய்நிகர் காங்கிரஸ் , அல்லாத தசை ஆக்கிரமிப்பு சிறுநீர்ப்பை புற்றுநோய் , ஆண்டு ஐரோப்பிய சங்கம் , மருத்துவ அறிவியல் , சிறுநீரகம் புற்றுநோயியல் ,

Nucleix Presents Clinical Data at EAU21 Virtual Congress Which Demonstrates Promising Advances in the Care of Bladder Cancer Patients - Press Release


Data Includes First Real World Evidence on Alternating Bladder EpiCheck® and Cystoscopy for Surveillance of Non-Muscle Invasive Bladder Cancer (NMIBC)
Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced data from two abstracts featuring its Bladder EpiCheck® test at the 36th Annual European Association of Urology (EAU) Virtual Congress.
The first abstract titled, “Real world evidence of alternating cystoscopy/cytology with Bladder EpiCheck in NMIBC surveillance,” shows the results of a pilot performed at Radboud University Medical Center evaluating the feasibility and clinical outcomes of alternating between cystoscopy/cytology and Bladder EpiCheck in non-muscle invasive bladder cancer (NMIBC) surveillance. To alleviate the burden of invasive and costly standard surveillance methods on patients, urine collection was performed at home and shipped to a central lab to perform the Bladder EpiCheck test. In t ....

United States , Comunidad Autonoma De Cataluna , Fred Witjes , Alberto Breda , Radboud University Medical Center , European Association Of Urology , Radboud University , Virtual Congress , Data Includes First Real World Evidence , Alternating Bladder Epicheck , Non Muscle Invasive Bladder Cancer , Bladder Epicheck , Annual European Association , Medical Sciences , Radboud University Medical , Lung Epicheck , Urology Oncology , ஒன்றுபட்டது மாநிலங்களில் , காமுனிடட தன்னாட்சி டி கடலுள் , ஆல்பர்டோ ப்ரேடா , ஐரோப்பிய சங்கம் ஆஃப் சிறுநீரகம் , மெய்நிகர் காங்கிரஸ் , அல்லாத தசை ஆக்கிரமிப்பு சிறுநீர்ப்பை புற்றுநோய் , ஆண்டு ஐரோப்பிய சங்கம் , மருத்துவ அறிவியல் , சிறுநீரகம் புற்றுநோயியல் ,

EAU 2014 - Debate: Surgical treatment of muscle invasive bladder cancer: Cost comparison analysis


EAU 2014 - Debate: Surgical treatment of muscle invasive bladder cancer: Cost comparison analysis - Session Highlights
STOCKHOLM, SWEDEN (UroToday.com) - Dr. R. Gaston presented the pro-side of the debate in favor of robotic-assisted radical cystectomy (RARC).
The EAU guidelines state that RARC does not improve oncologic outcomes, rather surgical expertise does (Grade A recommendation). In retrospective series, complication rates are comparable between open and robotic cystectomy (ranging from 11-50%). In a number of small series, no significant difference in positive surgical margin rate and lymph node yield has been demonstrated between RARC and open cystectomy (OC). At least one small prospective randomized-controlled trial has confirmed the non-inferiority of RARC to ORC. ....

European Association Of Urology , Saint Augustin , Nationwide Inpatient Sample , Annual European Association , ஐரோப்பிய சங்கம் ஆஃப் சிறுநீரகம் , துறவி ஆகஸ்டின் , நாடு முழுவதும் உள்நோயாளி மாதிரி , ஆண்டு ஐரோப்பிய சங்கம் ,